BENNETT C FRANK
EVP, Chief Scientific Officer
BENNETT C FRANK has filed 10 SEC Form 4 filings (25 transaction rows) across 1 company, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Sep 3, 2026.
On the most recent filing, BENNETT C FRANK is listed as EVP, Chief Scientific Officer at IONIS PHARMACEUTICALS INC. Inside the rolling window, BENNETT C FRANK reported no open-market purchases and 5 open-market sales totaling $16.7M in IONS. The largest disclosed transaction in the window is a sale of 85,089 IONS shares on Feb 2, 2026, worth $7.1M.
Companies traded
Other insiders at IONS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$16.7M
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
Frequently asked questions
How many SEC Form 4 filings has BENNETT C FRANK made?
BENNETT C FRANK has filed 10 SEC Form 4 filings (25 transaction rows) across 1 company since 2025.
Which companies does BENNETT C FRANK trade?
BENNETT C FRANK has filed SEC Form 4 disclosures for 1 company, including IONS.
When was BENNETT C FRANK's most recent SEC Form 4 filing?
BENNETT C FRANK's most recent SEC Form 4 filing on Tracefour is dated Sep 3, 2026.
What is BENNETT C FRANK's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, BENNETT C FRANK is listed as EVP, Chief Scientific Officer.
What is BENNETT C FRANK's total buy and sell value in the current window?
Inside the rolling retention window, BENNETT C FRANK bought $0 and sold $16.7M based on SEC Form 4 filings.
What was BENNETT C FRANK's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 85,089 IONS shares on 2026-02-02, worth $7.1M, per SEC Form 4 filings.